2
Total deals
$967.0M
Total value
$483.5M
Avg deal
$935.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Eyetech Pharmaceuticals
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel…
|
2005-08-22 | Acquisition | Complete | $935.0M | Deal → |
| 2 |
Cell Pathways
Cell Pathways develops small molecule-based drugs for cancer treatment.
|
2003-02-10 | Acquisition | Complete | $32.0M | Deal → |